Pharmaceutical News

RSS

Study investigates effects of glucose-lowering drug in preventing damage to the kidneys

New research presented at the annual meeting of the European Association for the Study of Diabetes and published simultaneously in The Lancet Diabetes & Endocrinology shows how the glucose-lowering drug lixisenatide can slow or prevent damage to the kidneys in macro-albuminuric patients with type 2 diabetes mellitus and cardiovascular disease.

3 Oct 2018

VA adding opioid antidote to defibrillator cabinets for quicker overdose response

It took more than 10 minutes for paramedics to arrive after a housekeeper found a man collapsed on the floor of a bathroom in a Boston Veteran Affairs building.

3 Oct 2018

Natural compound found in grapes may protect against cancer

Lung cancer is the deadliest form of cancer in the world, and 80% of death are related to smoking. In addition to tobacco control, effective chemoprevention strategies are therefore needed.

3 Oct 2018

Generics manufacturer Zentiva becomes an independent organization

Today marks generics manufacturer Zentiva's first day as an independent organization, following completion of the company's previously announced divestment from Sanofi.

3 Oct 2018

Researchers find ALS drug as potential treatment for prostate cancer

Researchers have discovered a new use for an old drug as a potential treatment for prostate cancer. The findings are published in the journal The Prostate.

3 Oct 2018

Spero Health launched to tackle the rising opioid crisis

Spero Health, Inc., a newly formed healthcare organization specializing in local, affordable, outpatient care for individuals suffering from substance use disorder, announced that it has acquired investment growth capital to meet the demand in communities across the country for high-quality, comprehensive and integrated addiction treatment services.

3 Oct 2018

Researchers assess effects of adding dapagliflozin to metformin or insulin in type 2 diabetes patients

Researchers used continuous glucose monitoring to assess the effects of adding dapagliflozin to a regimen of either metformin or insulin in patients with type 2 diabetes and found significant reductions in mean glucose and other glycemic factors, with greater improvements seen in patients taking metformin compared to insulin.

3 Oct 2018

New supplemental health products launched to complement Anthem medical plans

Anthem Blue Cross and Blue Shield now offers employer-sponsored voluntary accident, critical illness and hospital indemnity insurance products, for effective dates beginning January 1, 2019.

3 Oct 2018

Aggressive breast cancer cells hijack protective protein to aid growth

A new study has revealed that a protein known to protect healthy cells also protects cancer cells in aggressive breast cancer.

2 Oct 2018

Excessive use of erectile-dysfunction medication could lead to long-term vision problems

In a first-of-its-kind study, Mount Sinai researchers have shown that color vision problems caused by retinal damage on a cellular level can result from a high dose of sildenafil citrate, the popular erectile-dysfunction medication sold under the brand name Viagra.

1 Oct 2018

Why patients with ALL relapse after CAR-T cell therapy

Researchers have made a new discovery about a rare mechanism that triggers the relapse of acute lymphoblastic leukemia (ALL) after CAR T cell therapy.

1 Oct 2018

Why patients with ALL relapse after CAR-T cell therapy

Researchers have made a new discovery about a rare mechanism that triggers the relapse of acute lymphoblastic leukemia (ALL) after CAR T cell therapy.

1 Oct 2018

Many Alzheimer's patients are taking two or more psychotropic drugs

Up to 50% of people with Alzheimer’s disease now take a psychotropic drug and one-fifth use a combination of two or more psychotropic drugs.

1 Oct 2018

Gangrene-causing bacteria show promise as cancer treatment

Researchers have found that the bacteria responsible for causing gangrene could also be used to treat patients with certain cancers.

1 Oct 2018

Up to half of people with Alzheimer's disease use psychotropic drug, finds study

Up to half of people with Alzheimer's disease use a psychotropic drug, and one in five uses two or more psychotropics concomitantly, according to a study conducted at the University of Eastern Finland.

1 Oct 2018

Researchers investigate ability of Masimo ORi to reduce time ICU patients experience hyperoxemia

Masimo announced today the findings of an abstract presented at the 2018 Congress of the French Society of Anesthesia and Resuscitation in Paris in which researchers at CHU Angers in France investigated the ability of Masimo ORi™ to help clinicians reduce the number of days ICU patients experience hyperoxemia while on mechanical ventilation.

1 Oct 2018

Eisai's antiepileptic drug receives FDA approval to treat partial-onset seizures in pediatric patients

Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration for an indication expansion for Eisai's antiepileptic drug Fycompa (perampanel) to cover partial-onset seizures in pediatric patients with epilepsy 4 years of age and older.

1 Oct 2018

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

The U.S. Food and Drug Administration today approved a new drug, Arikayce, for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex in a limited population of patients with the disease who do not respond to conventional treatment.

29 Sep 2018

Researchers design new combination therapy for reducing NSCLC cell growth

Lung cancer is the leading cause of cancer death among men and women. About 85 percent of lung cancers are non-small cell lung cancer. For a handful of these patients, therapies that target specific genetic mutations are effective.

29 Sep 2018

FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous cell carcinoma or locally advanced CSCC who are not candidates for curative surgery or curative radiation.

28 Sep 2018

Pharmaceutical News

Study investigates effects of glucose-lowering drug in preventing damage to the kidneys

VA adding opioid antidote to defibrillator cabinets for quicker overdose response

Natural compound found in grapes may protect against cancer

Generics manufacturer Zentiva becomes an independent organization

Researchers find ALS drug as potential treatment for prostate cancer

Spero Health launched to tackle the rising opioid crisis

Researchers assess effects of adding dapagliflozin to metformin or insulin in type 2 diabetes patients

New supplemental health products launched to complement Anthem medical plans

Aggressive breast cancer cells hijack protective protein to aid growth

Excessive use of erectile-dysfunction medication could lead to long-term vision problems

Why patients with ALL relapse after CAR-T cell therapy

Why patients with ALL relapse after CAR-T cell therapy

Many Alzheimer's patients are taking two or more psychotropic drugs

Gangrene-causing bacteria show promise as cancer treatment

Up to half of people with Alzheimer's disease use psychotropic drug, finds study

Researchers investigate ability of Masimo ORi to reduce time ICU patients experience hyperoxemia

Eisai's antiepileptic drug receives FDA approval to treat partial-onset seizures in pediatric patients

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

Researchers design new combination therapy for reducing NSCLC cell growth

FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Latest News